Concepedia

Claude Nicaise

CN

Statistics

Publications

32

Citations

3.2K

H-Index

20

Active since

1982

Affiliations

Bristol-Myers Squibb (United States)(Current)

The University of Texas MD Anderson Cancer Center

Bristol-Myers Squibb (Germany)

Institut Jules Bordet

University of California, Los Angeles

Claude Nicaise is an author at Bristol-Myers Squibb (United States) specializing in oncology, medicine, and pharmacology.

Publications per year

1982–2008

32

Publications

32

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +15

Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis

Neil P. Shah, Corynn Kasap, Christopher Weier et al. · Cancer Cell · 2008 · 229 citations · Full text

, , +12

Dasatinib (BMS-354825) is active in Philadelphia chromosome–positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Dan Jones et al. · Blood · 2006 · 163 citations

, , +9

Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer.

Gary E. Goodman, Ingegerd Hellström, Laura Brodzinsky et al. · Journal of Clinical Oncology · 1990 · 103 citations

, , +17

Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.

Robert S. Benjamin, Sewa S. Legha, Shreyaskumar Patel et al. · PubMed · 1993 · 85 citations

, , +7

1–5 of 32